stockportfolio.pro
Stocks / DXCM vs IQV
DXCM vs IQV
DexCom, Inc. and IQVIA Holdings Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| DexCom, Inc. (DXCM) | IQVIA Holdings Inc. (IQV) | |
|---|---|---|
| Market cap | $30.2B | $31.1B |
| Revenue (latest FY) | $4.66B | $16.31B |
| Net income (latest FY) | $836.30M | $1.36B |
| Revenue growth (5y CAGR) | 19.3% | 7.5% |
| Net margin | 17.9% | 8.3% |
| Return on equity | 30.5% | 20.9% |
| P/E ratio | 32.9 | 23.1 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 7 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open DXCM — free Open IQV — freeFrequently asked questions
Which is bigger, DXCM or IQV?
IQVIA Holdings Inc. is larger by market capitalization — $31.1B versus $30.2B.
Which grows faster, DXCM or IQV?
Over the last five fiscal years, DexCom, Inc. grew revenue faster — 19.3%/yr versus 7.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.